PROCEPT BioRobotics (NASDAQ:PRCT) stock is trading on Monday after the company released better-than-expected third-quarter earnings. The company reported EPS loss of $(0.40), down from $(0.51) a year ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts. On August 7, Wells Fargo maintained its Overweight rating on PROCEPT BioRobotics Corporation ...
BofA Securities recently downgraded PROCEPT BioRobotics from Buy to Neutral, citing slowing utilization growth and moderating system sales for its Aquablation technology amid tighter hospital capital ...
In the Europe-wide FIThydro project, TalTech researchers worked with industry partners to study existing hydroelectric power plants. Together with researchers across Europe, they developed new ...
Why is this unit important? The next frontier in robotics will take inspiration from biology to design robots that are soft, smart, green and social to address important societal challenges. From ...
Carnegie Mellon University has developed a snake-like robot that can work underwater, making it a tool that could prove beneficial for inspecting boats and underwater infrastructure and completing ...
Total revenue of $79.2 million for the second quarter of 2025, an increase of 48% compared to the prior year period in 2024 U.S. handpiece and consumables revenue of $43.1 million for the second ...
Case Western Reserve roboticist Roger Quinn, neuroscientist Hillel Chiel to lead $8 million, five-year National Science Foundation NeuroNex Network project seeking next level of control of ...
Procept BioRobotics reported its second-quarter 2025 earnings, exceeding expectations with an actual EPS of -$0.35, compared to a forecast of -$0.41. Revenue also surpassed projections, reaching $79.2 ...
PROCEPT BioRobotics (NASDAQ: PRCT) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here's a brief overview of what investors should keep in mind before the announcement.
In the latest quarter, 6 analysts provided ratings for PROCEPT BioRobotics (NASDAQ:PRCT), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results